chemical information
CAS RN:

50-29-3

Chemical Class:

Organochlorine Pesticide (OC)

Manufacturing/Use Status

banned for use/manufacture in the U.S.

Found in these people:

Davis Baltz, Andrea Martin, Lexi Rome, Sharyle Patton, Bill Moyers, Lucy Waletsky, Kathy Fowler, Anonymous Adult 1, U.S. Representative Louise Slaughter, Sara Corbett

Found in these locations:

Berkeley, CA; Sausalito, CA; Mill Valley, CA; Bolinas, CA; NJ, USA; Pleasantville, NY; Rockville, MD; Upstate New York, NY; NY, USA


Summary

The most recent National Toxicology Program Report on Carcinogens list DDT as "reasonably anticipated to be a human carcinogen" (NTP 2002). DDT is considered to be a "probable" human carcinogen by the EPA, associated with non-Hodgkin's lymphoma and multiple myelomas. Some studies have detected increased risk of lung cancer in workers exposed to DDT. Weak associations have been made between DDT and another DDT metabolite, DDD, and pancreatic cancer. An association with breast cancer is equivocal, with some studies finding a positive relationship while others do not. In humans, DDT poisoning can result in excitability, tremors, seizures, dizziness, headache, fatigue, vomiting and altered liver enzyme activity (ATSDR 2002a). A recent study in humans compared the length of gestation in children born between 1959 and 1966, when DDT use was widely used in the US, with maternal levels of DDE (a metabolite of DDT) taken from stored blood samples. Levels of maternal DDE were strongly associated with pre-term birth and birth weight, which was corrected for "gestational" age (Longnecker 2001).

Effects of DDT in laboratory animals include liver tumors, lung tumors, leukemia, adrenal toxicity (tumors, cellular effects of the adrenal cortex and medulla), thyroid toxicity (decreased capacity to concentrate iodide), kidney toxicity and immune system toxicity. Neurotoxic effects of DDT include tremors, convulsion, paralysis, decreased central nervous system lipid, phospholipid and cholesterol content. DDT exposure early in life causes decreased growth, mortality, decreased levels of brain muscarinic acetylcholine receptors, increased spontaneous motor activity in adulthood and decreased learning. In the female, DDT causes numerous effects on the reproductive system, including decreased fertility, early pregnancy loss, increased uterine weight (a sign of estrogenicity), altered estrous cycling (the rodent equivalent of menstrual cycle) and early onset of puberty. In males, DDT causes decreased testis weight and decreased testosterone content in the testes (ATSDR 2002a).




4,4'-DDT

Organochlorine chemical, a class largely banned in the U.S. that builds up in the body over time, linked to cancer and reproductive harm.

4,4'-DDT has been found in 14 of the 27 people tested in EWG/Commonweal studies. It has also been found in 1,182 of the 4,821 people tested in CDC biomonitoring studies.


Top health concerns for 4,4'-DDT (References)

health concern or target organ weight of evidence
Cancerlimited
Reproduction and fertilityunknown
Birth defects and developmental delaysprobable

Other health concerns for 4,4'-DDT (References)

health concern or target organ weight of evidence
Endocrine systemknown
Persistent, accumulates in wildlife and/or peopleprobable
Wildlife and environmentprobable
Gastrointestinal (including liver)limited
Cardiovascular systemlimited
Hematologic (blood) systemlimited
Kidney and renal systemlimited

Violations, restrictions, and warnings for 4,4'-DDT (References)

Unsafe for use in cosmetics, Canada


Other relevant risk considerations for 4,4'-DDT (References)

Wildlife and environmental toxicity



Results for 4,4'-DDT

in blood serum (lipid weight)

Showing results from EWG/Commonweal Study #1, industrial chemicals and pesticides in adults, EWG/Commonweal Study #4, industrial chemicals and pesticides in cord blood, San Francisco Reporter, EWG Study #3, industrial chemicals and pesticides in adults, EWG Study #8, chemicals in mother and 2 children

EWG/Commonweal results

  • geometric mean: 0.207 ng/g (lipid weight) in blood serum
  • found in 14 of 27 people in the group

CDC biomonitoring results

  • geometric mean: 6.55 ng/g (lipid weight) in blood serum
  • found in 1182 of 4821 people in the group
0 ng/g (lipid weight) in blood serum 3610


4,4'-DDT results


Detailed toxicity classifications (References)

classification governing entity/references
Toxic; Toxic if swallowed; Limited evidence of a carcinogenic effect (European Union classification); Limited evidence of a carcinogenic effect; Dangerous for the environment; Very toxic to aquatic organismsEuropean Union - Classification & Labelling
A3- Confirmed animal carcinogen with unknown relevance to humans, ACGIH (American Conference of Governmental Industrial Hygeinists)Amer Conf of Gov't Industrial Hygienists - Carcinogens
Assoc of Occupational and Environmental Clinics - Asthmagens
Assoc of Occupational and Environmental Clinics - Asthmagens
Prohibited from use in Canadian cosmeticsCanada's Cosmetic Ingredient Hotlist
Priority water pollutant under the Clean Water ActEPA Water Quality Standards Database
EPA: known endocrine disruptorIllinois EPA Chemicals Associated with Endocrine System
Group B2: Probable human carcinogen - sufficient data in animals (EPA classification)EPA Integrated Risk Information System (IRIS)
Bioaccumulative - can build up in the environment, food chain, and people, with the rate of intake exceeding the rate of eliminationNational Library of Medicine HazMap
IARC Group 2B: possible human carcinogen (International Agency for Research on Carcinogens)Inter'l Agency for Research on Cancer (IARC) Carcinogens
Reasonably anticipated to be a human carcinogen (National Toxicology Program classification)NTP Report on Carcinogens, 11th Edition
Persistent, bioaccumulative toxicant - European Chemicals Bureau PBT working groupEU (2006). PRIO database - a tool for risk reduction of chemicals. Secondary PRIO database - a tool for risk reduction of chemicals. Secondary Kemi. Place Published, Kemi-Swedish Chemicals Inspectorate.
Persistent, bioaccumulative toxicant - Great Lakes Binational Strategy, Tier 1 concern (highest), targeted for phase-outGreat Lakes BTS (Binational Toxics Strategy). 1997. Canada-United States Strategy for the Virtual Elimination of Persistent Toxic Substances in the Great Lakes. Appendix I - Level 1 and Level 2 substances.
Persistent, bioaccumulative toxicant - Oslo-Paris (OSPAR) Convention for the Protection of the Marine Environment of the North-East Atlantic, chemical of concernOSPAR (2002). OSPAR List of Substances of Possible Concern. Secondary OSPAR List of Substances of Possible Concern. Secondary OSPAR. Place Published, OSPAR Convention for the Protection of the Marine Environement of North-East Atlanic.
Persistent, bioaccumulative toxicant - targeted for restrictions under international treaty (Stockholm Convention on Persistent Organic Pollutants, or POPs Convention)United Nations Environment Programme/POPs Treaty (2001)
Reproductive effects - weight of evidence unknown/unassessedDamgaard, I. N., N. E. Skakkebaek, et al. (2006). Persistent pesticides in human breast milk and cryptorchidism. Environ Health Perspect 114(7): 1133-8.
Gastrointestinal or liver toxicity hazards: suspectedATSDR, MALA, RTECS
Endocrine toxicity hazards: suspectedBKH, BRUC, IL-EPA, JNIHS, KEIT, RTECS, WWF
Cardiovascular or blood toxicity hazards: suspectedLADO, MALA, RTECS
Kidney toxicity hazards: suspectedMERCK
Developmental toxicity hazards: recognizedP65
Cancer hazards: recognizedP65
Reproductive toxicity hazards: recognizedP65